U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07388615) titled 'The Effect of Echinacea (Immulant (R)) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children' on Jan. 18.
Brief Summary: This study aims to:
1. To evaluate the effectiveness of Immulant (R) addition to standard treatment in reducing clinical symptoms of Cryptosporidiosis in immunocompromised children.
2. To measure the changes in parasite count in stool samples after treatment with Immulant (R).
3. To assess the safety and tolerability of Immulant (R) in children participating in the study.
Study Start Date: Jan. 18
Study Type: INTERVENTIONAL
Condition:
Cryptosporidium Infection
Intervention:
DRUG: Echinacea Ex...